An advisory committee for the Facilities for Illness Management and Prevention declined to vote on the destiny of Johnson & Johnson’s COVID-19 vaccine Wednesday, probably leaving in place a pause on the vaccine’s use till the committee reconvenes in seven to 10 days.
The CDC’s Advisory Committee on Immunization Practices, or ACIP, expects that the approaching week or so will present further knowledge and analyses on the vaccine’s potential dangers. Till it has extra data, ACIP opted to offer no new suggestions on using the vaccine.
On the desk, nevertheless, was all the pieces from recommending towards use of the vaccine altogether; recommending that solely sure teams obtain the vaccine, akin to solely males or solely folks over a sure age; or recommending that the pause be lifted and use proceed in all adults as earlier than.
Learn 12 remaining paragraphs | Feedback